(2010) Japan PPI (standard dose b.i.d.) Clarithromycin (200–400 mg b.i.d.) Amoxicillin (750 mg b.i.d.) 7 Metronidazole-containing triple therapy is not recommended as first-line treatment ...

Chiesi is hoping real world evidence will show its latest COPD triple therapy can help cut hospital admissions for the disease. Trimbow (beclometasone+formoterol+glycopyrronium) combines an ...

Lipid metabolism has emerged as a central player in the progression and therapy resistance of breast cancer, particularly the aggressive subtype known as triple-negative breast cancer (TNBC). This ...

The FDA has just handed an advantage to GlaxoSmithKline’s triple therapy for chronic obstructive pulmonary disease (COPD) by rejecting AstraZeneca’s PT010, a close competitor. AZ has confirmed ...

The FDA has granted breakthrough therapy designation to BCB-276 for the treatment of diffuse intrinsic pontine glioma (DIPG), an incurable pediatric brain tumor. BCB-276 is an investigational chimeric ...

We have previously postulated that targeting MNKs sensitizes cells to therapy induced cellular stress (Martinez et al. PLOSone, 2015). In this work, we describe the impact of EB1 on cell fate in the ...

BrainChild Bio’s lead drug candidate is BCB-276, an autologous CAR T-cell therapy that targets the immune checkpoint B7-H3, that is advancing in clinical trials for the treatment of diffuse intrinsic ...

Search for other works by this author on: ...

Pediatric cancer patients and their caregivers ... non-cancer related testing such as infectious disease testing, and post-cancer therapy testing such as testing for recurrence.

Breakthrough Therapy Designation is based on the encouraging ... Children’s and demonstrates our continued momentum in pediatric brain cancer research,” said Dr. Jeff Sperring, Chief Executive ...